Expression of cytokeratin-20 in pancreatic cancer: An indicator of poor outcome after R0 resection

Surgery

Volumn 139, Issue 1, 2006, Pages 104-108

  Schmitz Winnenthal, Friedrich Hubertus ^a   Volk, Christine ^a   Helmke, Burckhard ^a   Berger, Sara ^a   Hinz, Ulf ^a   Koch, Moritz ^a   Weitz, Jürgen ^a   Kleeff, Jörg ^a   Friess, Helmut ^a   Zöller, Margot ^b   Büchler, Markus Wolfgang ^a   Z'graggen, Kaspar ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Klinik Beau Site   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20;

ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; TISSUE SECTION;

CARCINOMA, PANCREATIC DUCTAL; FOLLOW-UP STUDIES; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 29144492095     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.06.058     Document Type: Article

References (37)

1. S.R. Bramhall, W.H. Allum, A.G. Jones, A. Allwood, C. Cummins, and J.P. Neoptolemos Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study Br J Surg 82 1995 111 115
2. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, and M.J. Thun Cancer statistics, 2003 CA Cancer J Clin 53 2003 5 26
3. R.J. Geer, and M.F. Brennan Prognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg 165 1993 68 72
4. S.S. Nitecki, M.G. Sarr, T.V. Colby, and J.A. van Heerden Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving? Ann Surg 221 1995 59 66
5. J.D. Birkmeyer, A.L. Warshaw, S.R. Finlayson, M.R. Grove, and A.N.A. Tosteson Relationship between hospital volume and late survival after pancreaticoduodenectomy Surgery 126 1999 178 183
6. S.F. Sener, A. Fremgen, H.R. Menck, and D.P. Winchester Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1999 1 7
7. T.A. Sohn, C.J. Yeo, and J.L. Cameron Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 2000 567 579
8. M. Wagner, C. Redaelli, M. Lietz, C.A. Seiler, H. Friess, and M.W. Buchler Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 2004 586 594
9. C. Sperti, C. Pasquali, A. Piccoli, and S. Pedrazzoli Recurrence after resection for ductal adenocarcinoma of the pancreas World J Surg 21 1997 195 200
10. U. Guller, P. Zajac, and A. Schnider Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer Ann Surg 236 2002 768 775
11. P. Kienle, J. Weitz, and R. Klaes Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma Arch Surg 135 2000 213 218
12. F.H. Schmitz-Winnenthal, H. Weckauf, and S. Haufe Detection and prognostic relevance of cytokeratin 20 in differentiated and anaplastic thyroid carcinomas by RT-PCR Surgery 134 2003 964 971
13. E. Soeth, C. Roder, H. Juhl, U. Kruger, B. Kremer, and H. Kalthoff The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase- chain reaction is related to the stage of disease Int J Cancer 69 1996 278 282
14. T. Weber, J. Lacroix, and S. Worner Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin-releasing peptide RT-PCR Int J Cancer 103 2003 126 131
15. J. Weitz, P. Kienle, and J. Lacroix Dissemination of tumor cells in patients undergoing surgery for colorectal cancer Clin Cancer Res 4 1998 343 348
16. J. Weitz, P. Kienle, and A. Magener Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow Clin Cancer Res 5 1999 1830 1836
17. K. Z'graggen, B.A. Centeno, C. Fernandez-del Castillo, R.E. Jimenez, J. Werner, and A.L. Warshaw Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients Surgery 129 2001 537 546
18. V.V. Lukyanchuk, H. Friess, J. Kleeff, S.P. Osinsky, E. Ayuni, and D. Candinas Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers Anticancer Res 23 2003 2711 2716
19. K. Albers, and E. Fuchs The molecular biology of intermediate filament proteins Int Rev Cytol 134 1992 243 279
20. M.H. Schüssler, A. Skoudy, F. Ramaekers, and F.X. Real Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer Am J Pathol 140 1992 559 568
21. L. Bouwens Cytokeratins and cell differentiation in the pancreas J Pathol 184 1998 234 239
22. D. Ramos, S. Navarro, R. Villamon, M. Gil-Salom, and A. Llombart-Bosch Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder Cancer 97 2003 1876 1883
23. S. Wildi, J. Kleeff, and H. Maruyama Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer Clin Cancer Res 5 1999 2840 2847
24. M.W. Buchler, M. Wagner, B.M. Schmied, W. Uhl, H. Friess, and K. Z'graggen Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy Arch Surg 138 2003 1310 1314
25. Sobin LH, Wittekind CH. TNM classification of malignant tumors. 6th ed. Berlin: Springer Verlag; 2002.
26. D.C. Aison, S. Piantadosi, R.H. Hruban, W.C. Dooley, E.K. Fishman, and J.L. Cameron DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma J Surg Oncol 67 1998 151 159
27. J.A. DiGiuseppe, C.J. Yeo, and R.H. Hruban Molecular biology and the diagnosis and treatment of adenocarcinoma of the pancreas Adv Anat Pathol 3 1996 139 155
28. E. Silberstein, S. Walfish, and L. Lupu Twelve-year survival after the diagnosis of locally advanced carcinoma of the pancreas: a case report J Surg Oncol 75 2000 142 145
29. M. Dowsett, S.R. Ebbs, and J.M. Dixon Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer - a study from the IMPACT trialists J Clin Oncol 23 2005 2477 2492
30. S. Yamamoto, Y. Tomita, and Y. Hoshida Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma Clin Cancer Res 10 2004 2846 2850
31. M.S. Duxbury, E. Matros, and T. Clancy CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions Ann Surg 241 2005 491 496
32. A.V. Biankin, A.L. Morey, and C.S. Lee DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma J Clin Oncol 20 2002 4531 4542
33. F.A. Vlems, T. Wobbes, C.J. Punt, and G.N. van Muijen Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer Anticancer Res 23 2003 523 530
34. M. von Knebel Döberitz, J. Weitz, M. Koch, J. Lacroix, A. Schrodel, and C. Herfarth Molecular tools in the detection of micrometastatic cancer cells - technical aspects and clinical relevance Recent Results Cancer Res 158 2001 181 186
35. L. Bouwens Islet morphogenesis and stem cell markers Cell Biochem Biophys 40 2004 81 88
36. L. Bouwens, R.N. Wang, E. De Blay, D.G. Pipeleers, and G. Kloppel Cytokeratins as markers of ductal cell differentiation and islet neogenesis in the neonatal rat pancreas Diabetes 43 1994 1279 1283
37. M. Kayahara, T. Nagakawa, K. Ueno, T. Ohta, T. Takeda, and I. Miyazaki An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging Cancer 72 1993 2118 2123